Optical delineation of human malignant melanoma using second harmonic imaging of collagen
Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Se...
Saved in:
Published in | Biomedical optics express Vol. 2; no. 5; pp. 1282 - 1295 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Optical Society of America
01.05.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 2156-7085 2156-7085 |
DOI | 10.1364/BOE.2.001282 |
Cover
Abstract | Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates. |
---|---|
AbstractList | Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh
ex vivo
normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to
in vivo
tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (
p
<0.002). SHG imaging of
ex vivo
human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates. Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates. Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates. |
Author | Krenacs, T. Becker, D. L. Virich, G. Thrasivoulou, C. Korom, I. |
Author_xml | – sequence: 1 givenname: C. surname: Thrasivoulou fullname: Thrasivoulou, C. – sequence: 2 givenname: G. surname: Virich fullname: Virich, G. – sequence: 3 givenname: T. surname: Krenacs fullname: Krenacs, T. – sequence: 4 givenname: I. surname: Korom fullname: Korom, I. – sequence: 5 givenname: D. L. surname: Becker fullname: Becker, D. L. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21559140$$D View this record in MEDLINE/PubMed |
BookMark | eNptUTtPwzAQthCIlsfGjLyx0OJXEmdBAsRLqtQFBibLdS6pkWOXOEHi32NoQYDwcpbve_ju20PbPnhA6IiSKeW5OLucX0_ZlBDKJNtCY0azfFIQmW3_uI_QYYzPJB0hCsLlLhqlXlZSQcboab7qrdEOV-CsB93b4HGo8XJotcetdrbx2ve4Bad9aDUeovUNjmCCr_BSd23w1mDb6ubjPTFNcE434A_QTq1dhMNN3UePN9cPV3eT2fz2_upiNjFc8n5iSgbGCEO5Zjov-AJ4VWnIgNVMkAUpOKcgBV9UZVYXoigryQitqOCmrEVu-D46X-uuhkULlQHfd9qpVZf-1L2poK363fF2qZrwqjiRRSazJHCyEejCywCxV62NBtIUHsIQlcxzJkrBSEIe_7T69vhaZwKwNcB0IcYOamVs_7nT5GydokR9xKZSbIqpdWyJdPqH9KX7L_wdpnaZtg |
CitedBy_id | crossref_primary_10_3390_healthcare1010064 crossref_primary_10_1038_srep08879 crossref_primary_10_1002_jbio_201200059 crossref_primary_10_1038_s41598_022_25055_y crossref_primary_10_1364_BOE_3_002021 crossref_primary_10_1186_s42047_021_00089_0 crossref_primary_10_1364_BOE_5_001355 crossref_primary_10_1364_BOE_10_000514 crossref_primary_10_1364_BOE_505220 crossref_primary_10_1111_iwj_12789 crossref_primary_10_1117_1_JBO_17_6_066004 crossref_primary_10_1364_BOE_7_004480 crossref_primary_10_5005_jp_journals_10015_1442 crossref_primary_10_17650_1726_9776_2017_13_4_101_106 crossref_primary_10_1364_OSAC_425373 crossref_primary_10_1016_j_md_2015_11_002 crossref_primary_10_1117_1_BIOS_1_1_015004 crossref_primary_10_1007_s12127_013_0124_6 crossref_primary_10_1098_rsif_2013_0263 crossref_primary_10_3390_life14020231 crossref_primary_10_1002_jbio_201300176 crossref_primary_10_1016_j_biomaterials_2018_08_039 crossref_primary_10_1364_OE_20_021821 |
Cites_doi | 10.1023/B:CLIN.0000006824.41376.b0 10.1364/OL.28.002488 10.1016/j.gde.2009.10.011 10.1038/nm879 10.1063/1.437677 10.1007/s10585-008-9204-0 10.1007/s00403-001-0289-4 10.1016/0923-1811(95)00470-X 10.1016/j.sder.2009.06.007 10.1007/s10198-008-0127-0 10.1364/AO.10.002350 10.1529/biophysj.106.093740 10.1111/j.0022-202X.2004.23569.x 10.1111/j.1524-4725.2006.32053.x 10.1054/bjoc.1999.0978 10.1109/JQE.1977.1069615 10.1016/S1047-8477(02)00576-2 10.1136/gut.52.suppl_4.iv1 10.1117/1.2983664 10.4065/81.4.500 10.3322/canjclin.55.2.74 10.1158/1078-0432.CCR-05-2559 10.1001/archfaci.7.4.238 10.1007/s10555-005-1572-1 10.3322/caac.20074 10.1007/s00403-003-0429-0 10.1097/01.cmr.0000195700.42766.23 10.1117/1.1383294 10.1529/biophysj.104.047308 |
ContentType | Journal Article |
Copyright | 2011 Optical Society
of America 2011 OSA |
Copyright_xml | – notice: 2011 Optical Society of America 2011 OSA |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1364/BOE.2.001282 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Engineering |
EISSN | 2156-7085 |
EndPage | 1295 |
ExternalDocumentID | PMC3087585 21559140 10_1364_BOE_2_001282 |
Genre | Journal Article |
GrantInformation_xml | – fundername: UCL Business |
GroupedDBID | 4.4 53G 8SL AAFWJ AAWJZ AAYXX ADBBV AEDJG AENEX AFPKN AKGWG ALMA_UNASSIGNED_HOLDINGS AOIJS ATHME AYPRP AZSQR AZYMN BAWUL BCNDV CITATION DIK DSZJF E3Z EBS EJD GROUPED_DOAJ GX1 HYE KQ8 LPK M~E O5R O5S OFLFD OK1 OPJBK ROL ROS RPM TR6 NPM 7X8 5PM |
ID | FETCH-LOGICAL-c383t-c92ecc4c13a2a673be3ddae5e2f240b07331e843bd95f7479d8201d143c9f46c3 |
ISSN | 2156-7085 |
IngestDate | Thu Aug 21 18:18:19 EDT 2025 Fri Jul 11 00:58:21 EDT 2025 Mon Jul 21 05:54:34 EDT 2025 Tue Jul 01 02:13:40 EDT 2025 Thu Apr 24 22:52:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | (170.3880) Medical and biological imaging (180.4315) Nonlinear microscopy (180.1790) Confocal microscopy (190.1900) Diagnostic applications of nonlinear optics |
Language | English |
License | https://opg.optica.org/policies/opg-tdm-policy.json https://doi.org/10.1364/OA_License_v1#VOR-OA This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c383t-c92ecc4c13a2a673be3ddae5e2f240b07331e843bd95f7479d8201d143c9f46c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1364/BOE.2.001282 |
PMID | 21559140 |
PQID | 866249420 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3087585 proquest_miscellaneous_866249420 pubmed_primary_21559140 crossref_citationtrail_10_1364_BOE_2_001282 crossref_primary_10_1364_BOE_2_001282 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-01 |
PublicationDateYYYYMMDD | 2011-05-01 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biomedical optics express |
PublicationTitleAlternate | Biomed Opt Express |
PublicationYear | 2011 |
Publisher | Optical Society of America |
Publisher_xml | – name: Optical Society of America |
References | Roth (boe-2-5-1282-R16) 1979; 70 Hompland (boe-2-5-1282-R30) 2008; 13 Lien (boe-2-5-1282-R12) 2009; 144 Theodossiou (boe-2-5-1282-R14) 2006; 91 Brown (boe-2-5-1282-R22) 2003; 9 Campagnola (boe-2-5-1282-R20) 2001; 6 Sun (boe-2-5-1282-R23) 2003; 28 Wach (boe-2-5-1282-R7) 1996; 12 Wandel (boe-2-5-1282-R8) 2002; 293 Monhian (boe-2-5-1282-R4) 2005; 7 Ntayi (boe-2-5-1282-R5) 2003; 295 Varani (boe-2-5-1282-R6) 2000; 82 Lohela (boe-2-5-1282-R10) 2010; 20 Eves (boe-2-5-1282-R3) 2003; 20 Kuphal (boe-2-5-1282-R26) 2005; 24 Paoli (boe-2-5-1282-R11) 2009; 28 Gerger (boe-2-5-1282-R18) 2005; 124 Cox (boe-2-5-1282-R19) 2003; 141 Cummins (boe-2-5-1282-R24) 2006; 81 Rigel (boe-2-5-1282-R29) 2010; 60 Williams (boe-2-5-1282-R21) 2005; 88 Weinstock (boe-2-5-1282-R25) 2006; 12 Morris (boe-2-5-1282-R1) 2009; 10 Scoazec (boe-2-5-1282-R9) 2003; 52 Fikrle (boe-2-5-1282-R28) 2006; 16 Sheppard (boe-2-5-1282-R15) 1977; 13 de Giorgi (boe-2-5-1282-R27) 2006; 32 Parkin (boe-2-5-1282-R2) 2005; 55 Provenzano (boe-2-5-1282-R17) 2009; 26 Fine (boe-2-5-1282-R13) 1971; 10 16432455 - Melanoma Res. 2006 Feb;16(1):45-50 16027344 - Arch Facial Plast Surg. 2005 Jul-Aug;7(4):238-43 16610570 - Mayo Clin Proc. 2006 Apr;81(4):500-7 14530987 - Arch Dermatol Res. 2003 Nov;295(6):236-41 17130233 - Biophys J. 2006 Dec 15;91(12):4665-77 14713103 - Clin Exp Metastasis. 2003;20(8):685-700 19942428 - Curr Opin Genet Dev. 2010 Feb;20(1):72-8 15533922 - Biophys J. 2005 Feb;88(2):1377-86 12746261 - Gut. 2003 Jun;52 Suppl 4:iv1-6 19357625 - G Ital Dermatol Venereol. 2009 Apr;144(2):187-94 20111328 - Appl Opt. 1971 Oct 1;10(10):2350-3 12576020 - J Struct Biol. 2003 Jan;141(1):53-62 16442056 - Dermatol Surg. 2006 Feb;32(2):282-6 10682680 - Br J Cancer. 2000 Feb;82(3):657-65 14690123 - Opt Lett. 2003 Dec 15;28(24):2488-90 18791757 - Eur J Health Econ. 2009 Jul;10(3):267-73 15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 8814543 - J Dermatol Sci. 1996 Jun;12(2):118-26 11875642 - Arch Dermatol Res. 2002 Feb;293(12):601-8 20671054 - CA Cancer J Clin. 2010 Sep-Oct;60(5):301-16 12754503 - Nat Med. 2003 Jun;9(6):796-800 19782943 - Semin Cutan Med Surg. 2009 Sep;28(3):190-5 11516317 - J Biomed Opt. 2001 Jul;6(3):277-86 16609048 - Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2297s-2300s 15737188 - J Invest Dermatol. 2005 Mar;124(3):493-8 18766302 - Clin Exp Metastasis. 2009;26(4):357-70 15986132 - Cancer Metastasis Rev. 2005 Jun;24(2):195-222 19021430 - J Biomed Opt. 2008 Sep-Oct;13(5):054050 |
References_xml | – volume: 20 start-page: 685 year: 2003 ident: boe-2-5-1282-R3 publication-title: Clin. Exp. Metastasis doi: 10.1023/B:CLIN.0000006824.41376.b0 – volume: 28 start-page: 2488 year: 2003 ident: boe-2-5-1282-R23 publication-title: Opt. Lett. doi: 10.1364/OL.28.002488 – volume: 20 start-page: 72 year: 2010 ident: boe-2-5-1282-R10 publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/j.gde.2009.10.011 – volume: 9 start-page: 796 year: 2003 ident: boe-2-5-1282-R22 publication-title: Nat. Med. doi: 10.1038/nm879 – volume: 70 start-page: 1637 year: 1979 ident: boe-2-5-1282-R16 publication-title: J. Chem. Phys. doi: 10.1063/1.437677 – volume: 26 start-page: 357 year: 2009 ident: boe-2-5-1282-R17 publication-title: Clin. Exp. Metastasis doi: 10.1007/s10585-008-9204-0 – volume: 293 start-page: 601 year: 2002 ident: boe-2-5-1282-R8 publication-title: Arch. Dermatol. Res. doi: 10.1007/s00403-001-0289-4 – volume: 12 start-page: 118 year: 1996 ident: boe-2-5-1282-R7 publication-title: J. Dermatol. Sci. doi: 10.1016/0923-1811(95)00470-X – volume: 28 start-page: 190 year: 2009 ident: boe-2-5-1282-R11 publication-title: Semin. Cutan. Med. Surg. doi: 10.1016/j.sder.2009.06.007 – volume: 144 start-page: 187 year: 2009 ident: boe-2-5-1282-R12 publication-title: G. Ital. Dermatol. Venereol. – volume: 10 start-page: 267 year: 2009 ident: boe-2-5-1282-R1 publication-title: Eur. J. Health Econ. doi: 10.1007/s10198-008-0127-0 – volume: 10 start-page: 2350 year: 1971 ident: boe-2-5-1282-R13 publication-title: Appl. Opt. doi: 10.1364/AO.10.002350 – volume: 91 start-page: 4665 year: 2006 ident: boe-2-5-1282-R14 publication-title: Biophys. J. doi: 10.1529/biophysj.106.093740 – volume: 124 start-page: 493 year: 2005 ident: boe-2-5-1282-R18 publication-title: J. Invest. Dermatol. doi: 10.1111/j.0022-202X.2004.23569.x – volume: 32 start-page: 282 year: 2006 ident: boe-2-5-1282-R27 publication-title: Dermatol. Surg. doi: 10.1111/j.1524-4725.2006.32053.x – volume: 82 start-page: 657 year: 2000 ident: boe-2-5-1282-R6 publication-title: Br. J. Cancer doi: 10.1054/bjoc.1999.0978 – volume: 13 start-page: 912 year: 1977 ident: boe-2-5-1282-R15 publication-title: IEEE J. Quantum Electron. doi: 10.1109/JQE.1977.1069615 – volume: 141 start-page: 53 year: 2003 ident: boe-2-5-1282-R19 publication-title: J. Struct. Biol. doi: 10.1016/S1047-8477(02)00576-2 – volume: 52 start-page: 1i year: 2003 ident: boe-2-5-1282-R9 publication-title: Gut doi: 10.1136/gut.52.suppl_4.iv1 – volume: 13 start-page: 054050 year: 2008 ident: boe-2-5-1282-R30 publication-title: J. Biomed. Opt. doi: 10.1117/1.2983664 – volume: 81 start-page: 500 year: 2006 ident: boe-2-5-1282-R24 publication-title: Mayo Clin. Proc. doi: 10.4065/81.4.500 – volume: 55 start-page: 74 year: 2005 ident: boe-2-5-1282-R2 publication-title: CA Cancer J. Clin. doi: 10.3322/canjclin.55.2.74 – volume: 12 start-page: 2297s year: 2006 ident: boe-2-5-1282-R25 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-05-2559 – volume: 7 start-page: 238 year: 2005 ident: boe-2-5-1282-R4 publication-title: Arch. Facial Plast. Surg. doi: 10.1001/archfaci.7.4.238 – volume: 24 start-page: 195 year: 2005 ident: boe-2-5-1282-R26 publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-005-1572-1 – volume: 60 start-page: 301 year: 2010 ident: boe-2-5-1282-R29 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.20074 – volume: 295 start-page: 236 year: 2003 ident: boe-2-5-1282-R5 publication-title: Arch. Dermatol. Res. doi: 10.1007/s00403-003-0429-0 – volume: 16 start-page: 45 year: 2006 ident: boe-2-5-1282-R28 publication-title: Melanoma Res. doi: 10.1097/01.cmr.0000195700.42766.23 – volume: 6 start-page: 277 year: 2001 ident: boe-2-5-1282-R20 publication-title: J. Biomed. Opt. doi: 10.1117/1.1383294 – volume: 88 start-page: 1377 year: 2005 ident: boe-2-5-1282-R21 publication-title: Biophys. J. doi: 10.1529/biophysj.104.047308 – reference: 15533922 - Biophys J. 2005 Feb;88(2):1377-86 – reference: 16610570 - Mayo Clin Proc. 2006 Apr;81(4):500-7 – reference: 11875642 - Arch Dermatol Res. 2002 Feb;293(12):601-8 – reference: 20671054 - CA Cancer J Clin. 2010 Sep-Oct;60(5):301-16 – reference: 12576020 - J Struct Biol. 2003 Jan;141(1):53-62 – reference: 18766302 - Clin Exp Metastasis. 2009;26(4):357-70 – reference: 11516317 - J Biomed Opt. 2001 Jul;6(3):277-86 – reference: 15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 – reference: 16432455 - Melanoma Res. 2006 Feb;16(1):45-50 – reference: 19782943 - Semin Cutan Med Surg. 2009 Sep;28(3):190-5 – reference: 16442056 - Dermatol Surg. 2006 Feb;32(2):282-6 – reference: 15737188 - J Invest Dermatol. 2005 Mar;124(3):493-8 – reference: 12754503 - Nat Med. 2003 Jun;9(6):796-800 – reference: 14530987 - Arch Dermatol Res. 2003 Nov;295(6):236-41 – reference: 19021430 - J Biomed Opt. 2008 Sep-Oct;13(5):054050 – reference: 16027344 - Arch Facial Plast Surg. 2005 Jul-Aug;7(4):238-43 – reference: 14690123 - Opt Lett. 2003 Dec 15;28(24):2488-90 – reference: 12746261 - Gut. 2003 Jun;52 Suppl 4:iv1-6 – reference: 16609048 - Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2297s-2300s – reference: 19942428 - Curr Opin Genet Dev. 2010 Feb;20(1):72-8 – reference: 20111328 - Appl Opt. 1971 Oct 1;10(10):2350-3 – reference: 14713103 - Clin Exp Metastasis. 2003;20(8):685-700 – reference: 17130233 - Biophys J. 2006 Dec 15;91(12):4665-77 – reference: 8814543 - J Dermatol Sci. 1996 Jun;12(2):118-26 – reference: 19357625 - G Ital Dermatol Venereol. 2009 Apr;144(2):187-94 – reference: 18791757 - Eur J Health Econ. 2009 Jul;10(3):267-73 – reference: 10682680 - Br J Cancer. 2000 Feb;82(3):657-65 – reference: 15986132 - Cancer Metastasis Rev. 2005 Jun;24(2):195-222 |
SSID | ssj0000447038 |
Score | 2.072337 |
Snippet | Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1282 |
SubjectTerms | Optics in Cancer Research |
Title | Optical delineation of human malignant melanoma using second harmonic imaging of collagen |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21559140 https://www.proquest.com/docview/866249420 https://pubmed.ncbi.nlm.nih.gov/PMC3087585 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkRAcECyv8lj5AKcqpXUcJz4itLCAlr3sonKK7NhZKrVJ1TYI8esZT-w0XYq0cIkqvxJ1Po_H8yTklebMCFPEkS6tiTjTJpJwskQ6dVa4VCqF6ZpOv4iTC_5pmky3FnyMLtnoUfFrb1zJ_1AV2oCuLkr2HyjbLQoN8BvoC0-gMDyvReOzZauJNi6ovCf8oWJ-ARL2pXNzGS7sXFX1Qg0bVAys3R3YDF3Oaix_M1v4SkXOwRxQcemjw4KpFwP08T31EpM625_LznEDfUpWaj37UTfzukG96yj0fJ0Bl0W9zYeu7fPKVso7J20b61WNwPw46qshnF41OP213AoILKJ03NbfGdk9bZ7dsh6qkh7rhIOS7eXpseDOU_3seORyq4Zhu6mzrxxpnaMh2usEz2F2zvJ29k1yi6UgaLnI8OmkU8iNOQfuhxUMw2f7QAlY4E3_9bsizB_3kqvutT155fw-uecvGvRti5oH5IatDsndXvrJQ3L71DtWPCTfPJRoD0q0LilCiXZQogFKFKFEWyjRACXqoeRmBig9Ihfvj8_fnUS-6kZUxFm8iQrJYFvzYhIrpkQaaxsbo2xiWQnSn8YinzbjsTYyKeEyKo0TIg3I3YUsuSjix-Sgqiv7lFDY51lWGlumOuU8w2SQE6EYTwopeSEHZBj-yLzwKeldZZR5vo9uA_K6G71sU7H8ZRwNNMmBVzoDmKps3azzTAjGJWfjAXnSkqhbiDnz_IRDT7pDvG6AS8O-21PNvmM6dpdTEy7dz675ec_Jne3-eUEONqvGvgTBdqOPUCF0hLD8DaRrpBQ |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optical+delineation+of+human+malignant+melanoma+using+second+harmonic+imaging+of+collagen&rft.jtitle=Biomedical+optics+express&rft.au=Thrasivoulou%2C+C.&rft.au=Virich%2C+G.&rft.au=Krenacs%2C+T.&rft.au=Korom%2C+I.&rft.date=2011-05-01&rft.issn=2156-7085&rft.eissn=2156-7085&rft.volume=2&rft.issue=5&rft.spage=1282&rft_id=info:doi/10.1364%2FBOE.2.001282&rft.externalDBID=n%2Fa&rft.externalDocID=10_1364_BOE_2_001282 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2156-7085&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2156-7085&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2156-7085&client=summon |